Elementor #7271
Chemspec Europe 2026: Taros Chemicals at Europe’s Leading Fine and Speciality Chemicals Exhibition Taros Chemicals will attend Chemspec Europe 2026, one of Europe’s key trade fairs for the fine and
23. March 2026
BioSpring Europe 2026: Taros Chemicals to Participate in Leading Life Science Partnering Event
Taros Chemicals will participate in BIO-Europe Spring 2026, one of Europe’s leading partnering conferences for the biotechnology, pharmaceutical, and life science industries. The event brings together innovative biotech companies, pharmaceutical R&D teams, investors, and technology providers to explore new collaborations and advance scientific innovation.
Representing Taros Chemicals at the conference will be Dr. Anil Agarwal, Head of Medicinal Chemistry, and Youri Mesmoudi, Executive Vice President, who will meet partners to discuss collaboration opportunities in medicinal chemistry, drug discovery, and custom synthesis.
Medicinal Chemistry Expertise for Drug Discovery
With more than 25 years of experience in chemical research and custom synthesis, Taros Chemicals supports pharmaceutical and biotechnology companies with specialized expertise in small-molecule discovery and development.
The Taros team provides integrated support across the early stages of drug discovery, including:
Hit identification and hit-to-lead development
Lead optimization and medicinal chemistry programs
Structure-based drug design
Synthesis of complex small molecules
Development of novel chemical modalities, including PROTACs
These capabilities allow partners to accelerate their drug discovery pipelines while accessing advanced expertise in chemical innovation and molecule design.
Companies developing new therapeutic small molecules frequently collaborate with specialized chemistry partners such as Taros Chemicals to design, synthesize, and optimize complex compounds required for modern drug discovery programs.
Partnering Opportunities at BIO-Europe Spring
BIO-Europe Spring is recognized as one of the most important networking events in the European biotech ecosystem, providing a platform for strategic discussions between innovative companies and research partners.
During the event, Taros Chemicals looks forward to connecting with:
biotechnology companies advancing novel therapeutic programs
pharmaceutical R&D teams seeking medicinal chemistry expertise
research organizations developing new drug discovery technologies
partners interested in custom synthesis and collaborative chemistry programs
The Taros team welcomes discussions on flexible drug discovery collaborations, FTE-based medicinal chemistry support, and custom synthesis projects.
Event Details
Event: BIO-Europe Spring 2026
Industry: Biotechnology, Pharmaceuticals, Life Sciences
Format: International partnering conference
Companies attending BIO-Europe Spring and interested in discussing medicinal chemistry support, small-molecule discovery, or custom synthesis partnerships are invited to connect with the Taros team.
Frequently Asked Questions
What does Taros Chemicals offer to biotech and pharmaceutical companies?
Taros Chemicals provides medicinal chemistry, custom synthesis, and contract research services that support small-molecule drug discovery and development. The company collaborates with partners to design, synthesize, and optimize complex chemical compounds used in pharmaceutical research programs.
How does Taros support drug discovery programs?
Taros supports drug discovery through hit identification, hit-to-lead development, lead optimization, and synthesis of complex molecules. The company also provides expertise in structure-based drug design and emerging modalities such as PROTAC chemistry.
Why do biotech companies collaborate with medicinal chemistry CROs?
Drug discovery often requires specialized synthetic expertise and rapid molecule optimization. Medicinal chemistry CROs such as Taros Chemicals provide the capabilities needed to design, synthesize, and refine novel compounds, enabling biotech companies to advance their therapeutic programs more efficiently.
About Taros Chemicals
Taros Chemicals is a contract research and custom synthesis company based in Dortmund, Germany. The company specializes in complex molecule synthesis, medicinal chemistry and chemical innovation, supporting partners in the pharmaceutical, biotechnology and specialty chemicals industries. With more than 25 years of experience, Taros provides tailored chemical solutions from early discovery to scalable synthesis, including applications in cosmetic ingredient development. Get in touch with us!
About Taros
Staff Members
0
Ph.D. Degree
0
%
Nationalities Inhouse
0
Projects Executed
>
12400
Years Active
"Injections" Needed
999000
Latest News
Drug Discovery Chemistry 2026 ⎮Taros Chemicals to Attend Leading Medicinal Chemistry Conference
Drug Discovery Chemistry 2026: Taros Chemicals to Attend Leading Medicinal Chemistry Conference Taros Chemicals will attend Drug Discovery Chemistry 2026, a major international conference dedicated to medicinal chemistry, small-molecule drug
4. March 2026
BIO-Europe Spring 2026 ⎮Taros Chemicals to Attend Leading Biotech Partnering Conference
BioSpring Europe 2026: Taros Chemicals to Participate in Leading Life Science Partnering Event Taros Chemicals will participate in BIO-Europe Spring 2026, one of Europe’s leading partnering conferences for the biotechnology,
4. March 2026
in-cosmetics Global 2026 ⎮Taros Chemicals is Attending the Leading Cosmetic Ingredients Trade Fair
Taros is attending: in-cosmetics Global 2026 Taros Chemicals will attend in-cosmetics Global 2026, one of the world’s most important international trade fairs for cosmetic ingredients, formulation technologies and personal care
4. March 2026
Discovery Chemistry services to materialize your ideas
At Taros we regularly perform contract research with an emphasis on the design and synthesis of novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab scale to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative discovery chemistry services:
Biotechs
Biotechs simply concentrate on their research and development tasks while our experienced chemists take care of all related synthetic chemistry challenges.
Medtech and Healthcare
From new release mechanisms in band-aid material to the development of chemistry for innovative dual modes of action to help make use of new imaging techniques (PET).
Display Technologies
Innovative display technologies require performance chemicals that allow tomorrow’s visual applications in handheld devices, car interfaces or further intelligent equipment.
Pharma
Providing innovative but cost efficient early drug discovery services and technologies to our pharma customers is what drives our multidisciplinary scientists at Taros.
Chemical Industry
From literature research to pilot plant – we deliver sophisticated chemicals with full IP to our customers to help them achieve their product development goals.
Coatings and Dyes
Your R&D has a specific idea about how the surface should perform by modulating the coating or the curing? Get in touch with our scientists to discuss your chemistry challenge.
Research Institutes and Academia
Great academic research often requires industrial backing and excellent synthesis capacities to bring ideas to the market – for many years we have been closing that gap.
Flavors and Cosmetics
Get in touch with us if you’d like to discuss the development of new or the improvement of existing synthetic molecules for fragrances, skin care applications or aroma molecules.
Consumer Goods
Smarter consumer goods require both improved properties and chemicals that provide an acceptable ecological footprint during their entire life cycle.
We provide long-term added value to our diverse customers through discovery chemistry services and contract research
Our contract research focuses on holistic and cost-effective solutions of the highest quality for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. Thereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers with discovery chemistry services in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.
Taros Chemicals GmbH & Co. KG receives funding from the program European Regional Development Fund (ERDF / EFRE) by the state of North Rhine-Westphalia and the Europen Union.